"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
. therapy, hdl particle size got smaller (not a good thing) and the hdl worked less effectively to remove cholesterol from the body," mehta said.
.
a sign at a planned parenthood clinic is pictured in oklahoma city, in 2015.
.
.
the school in yarmouth that year had a low opt-out rate � 2 percent, the superintendent said � so there was a cap on the amount of disruption an illness could cause.
.
.
(soundbite of les pommes de ma douche's "trompettes de la renommee") transcript provided by npr, copyright npr.
.
.